medigraphic.com
ISSN 2218-6719 (Print)

2021, Number 3

<< Back Next >>

Rev Cub de Tec de la Sal 2021; 12 (3)

Manifestation of the eye clinic in Covid-19

Pérez FA, Suárez CI, Zazo ERM, González MJ

Language: Spanish
References: 19
Page: 3-8
PDF size: 421.80 Kb.


ABSTRACT

Introduction: the severe acute respiratory syndrome 2, SARS-CoV-2, is the cause of the coronavirus disease 2019. The Covid-19 epidemic began in Wuhan, China, and in a short time it spread to other continents. The ocular mucosa can be not only a site of entry for viruses, but also a source of contagion. Objective: to argue about the manifestation of the ocular clinic in Covid-19. Development: although a low percentage of ocular clinical manifestations is registered in patients with Covid-19, it is known that the virus can be isolated in the tear and conjunctiva; transmissibility through eye secretions is possible. It has been reported that viral conjunctivitis so far is the manifestation of the most frequent ocular symptoms reported in patients with a diagnosis of Covid-19, the eye condition is the first symptom or concomitant symptom. Advanced age, male sex, being a carrier of chronic diseases, smoking, and immunosuppression are factors with a worse prognosis. Adequate protection of ophthalmology personnel and health technologists in Optometry and Optics is of vital importance in the care of these patients. Conclusions: it was argued about the manifestation of the ocular clinic in covid-19, which contributes to enrich the promotion for health and the prevention of diseases in times of pandemic to the individual, the family and the community.


REFERENCES

  1. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. [Internet]. 2020 Jun [Cited 2020 Mayo 14]; 39(6):1011-9. Available from: https://www.10.1007/s10096-020-03874-z

  2. Zhou W. The coronavirus prevention Handbook. 101 Science-based tips that could save your life. Wuhan: Skyhorse Publishing; 2020.

  3. Mejía CR, Rodríguez-Alarcon JF, Garay-Ríos L, Enríquez-Anco MD, Moreno A, Huaytan-Rojas K, et al. Percepción de miedo o exageración que transmiten los medios de comunicación en la población peruana durante la pandemia de la COVID-19. Rev Cub Invest Bioméd. [Internet]. 2020 [Citado 14 Mayo 2020]; 39(2). Disponible en: http://www.revibiomedica.sld.cu/index.php/ibi/article/view/698

  4. Zhang T, Wu Q, Zhang Z. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Curr Biol. 2020 Apr; [Cited 2020 May 14]; 30(7): 1346-51. Available from: https://www.doi.org/10.1016/j. cub.2020.03.022

  5. Ma D, Chen CB, Jhanji V, Xu C, Yuan XL, Liang JJ, et al. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea. Eye (Lond). 2020; 34(7): 1212-9.

  6. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar [Cited 2020 May 14]; 579(7798):270-3. Available from: https://www.10.1038/s41586-020-2012-7

  7. Sociedad Española de Oftalmología. Recomendaciones para la atención a pacientes oftalmológicos en relación con emergencia COVID-19. SEO; 2020 [Citado 14 Mayo 2020]. Disponible en: https://www.oftalmoseo.com/documentacion/comunicado_conjunto_oftalmologia_covid19.pdf

  8. Wu P, Duan F, Luo Ch, Liu Q, Qu X, Liang L, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020 [Cited 2020 May 14]; 138(5):575–8. Available from: https://www.10.1001/jamaophthal- mol.2020.1291

  9. Xu M, Zhagn H, Niu X. COVID-19 patient firstly visiting eye doctor due to tarsadenitis and sub-conjunctival hemorrhage: A case report. Chin J Exp Ophthalmol. 2020 Apr; [Cited 2020 May 14]; 4, Case Report. Available from: https://www.10.3760/cma.j.cn.115989-20200228-00121

  10. Hong N, Yu W, Xia J, Shen Y, Yap M, Han W. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19. Acta Ophthalmol. [Internet]. 2020. [Cited 2020 May 14]; Disponible en: https://www.doi.org/10.1111/aos.14445

  11. Lange, C.; Wolf, J.; Auw-Haedrich, C.; Schlecht, A.; Boneva, S.; Lapp, T.; Horres, R.; Agostini, H.; Martin, G.; Reinhard, T.; et al. Expression of the COVID-19 receptor ACE2 in the human conjunctiva. J. Med. Virol., 2020. Disponible en: https://www.doi.org/10.1002/jmv.25981

  12. Güemes-Villahoz N, Burgos-Blasco B, Arribi-Vilela A, Arriola-Villalobos P, Rico-Luna CM, Cuiña-Sardiña R et al. Detecting SARS-CoV-2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID-19? J. Med. Virol. [Internet]. 2020. [Cited 2020 May 14]; Disponible en: https://www.doi.org/ 10.1002/jmv.26219

  13. Ye Y, Song Y, Yan M, Hu Ch, Chen X, Yu J, et al. Novel coronavirus pneumonia combined with conjunctivitis: three cases report. Chin J Exp Ophthalmol. [Internet]. 2020; [Cited 2020 May 14]; 38(03): 242-4. Available from: https://www.10.3760/cma.j.issn.2095-0160.2020.0006

  14. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med. [Internet]. 2020; [Cited 2020 May 14]; 382: 1708-20. Available from: https://www.10.1056/NEJMoa2002032

  15. Colavita F, Lapa D, Carletti F, Lalle E, Bordi L, Marsella P, et al. SARS-CoV-2 Isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med [Internet]. 2020 Apr [Cited 2020 May 14]; Available from: https://www.annals.org/aim/fullarticle/2764963

  16. Foulsham W, Coco G, Amouzegar A, Chauhan SK, Dana R. When clarity is crucial: regulating ocular surface immunity. Trends Immunol. [Internet]. 2018 Apr; [Cited 2020 May 14]; 39(4): 288-301. Available from: https://www.10.1016/j.it.2017.11.007

  17. Gegúndez-Fernández JA, Zarranz-Ventura J, Garay-Aramburu G, Múñoz-Negrete FJ, Mendicute-del-Barrio J, Pablo-Júlvez, L, et al. Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19. Arch. Soc. Esp. Oftalmol. 2020; 95(6):300-10.

  18. Rousseau A, Fenolland JR, Labetoulle M. SARS-CoV-2, COVID- 19 and the eye: An update on published data. J. Fr. Ophtalmol. 2020; 43(7): 642-52.

  19. Sociedad Chilena de Oftalmología (SOCHIOF). Recomendaciones Generales de la Sociedad Chilena de Oftalmología para minimizar el riesgo de infección por Covid-19 en nuestros centros de salud. Comunicado 2020. Santiago de Chile, Sociedad Chilena de Oftalmología, 2020. Disponible en: https://www.sochiof.cl/dinamicos/documentos/COVID-19recomendaciones-generales-final.pdf




2020     |     www.medigraphic.com